Virinchi (VIRINCHI)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Trading at a significant discount to book value: P/B of 0.48 against book value of ₹37.78
• Moderate leverage with debt-to-equity of 0.64, not excessively burdensome
• Reasonable promoter holding at 40.08%, aligning some interests
• Latest quarter still profitable with net profit of ₹2 crore despite weak environment

Concerns

• Profit growth severely negative at -55.97%, indicating deteriorating earnings power
• Piotroski F-Score of 3/9 points to weak financial health and operational inefficiency
• No dividend yield, offering no income buffer while waiting for a turnaround
• Return on equity and ROCE below 6%, far from acceptable capital allocation

AI Analysis

When I look at Virinchi, the first thing that catches my eye is the price-to-book ratio of 0.48. I am being asked to pay less than half of the book value of ₹37.78 for a rupee of assets. That is the kind of margin of safety Graham would appreciate. But a cheap price must be backed by evidence that the asset base can earn a reasonable return. Here, the evidence is troubling. Return on equity is just 5.64%, and ROCE is 5.44% — barely above the cost of borrowing, if at all. The company is not compounding wealth; it is merely preserving it, and maybe not even that. Sales have declined by 6.69%, and profit has collapsed by nearly 56%. The latest quarter shows sales of ₹77 crore but a net profit of only ₹2 crore — a margin so thin that any hiccup could wipe it out. The Piotroski F-Score of 3 out of 9 reinforces my caution: the financial health is weak, and the balance sheet is showing stress. Debt-to-equity of 0.64 is not alarming, but with falling earnings, debt becomes heavier. There is no dividend, so I cannot even be paid to wait. Promoter holding of 40.08% is reasonable, but that alone does not make a good business. In the classic Graham framework, this looks like an asset play, not a quality compounder. The market is giving it a low valuation for a reason. I would need to see a clear path to improving profitability, stronger operating discipline, and evidence that the software products business can generate consistent margins before I consider this a true bargain. For now, it is a watchlist candidate, not a conviction buy.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer